QuidelOrtho, BundefinedHLMANN Laboratories announce availability of turbo assays

QuidelOrtho (QDEL) and BundefinedHLMANN Laboratories announced the availability of the BundefinedHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho’s VITROS Systems as an MPA. Both particle-enhanced turbidimetric immunoassays, the fCAL turbo assay for fecal calprotectin measurement aids in the diagnosis of inflammatory bowel disease and its differentiation from irritable bowel syndrome, and the fPELA turbo assay for fecal pancreatic elastase aids in the determination of pancreatic insufficiency. The fCAL and fPELA turbo assays are both now available for use on QuidelOrtho’s VITROS Systems: fCAL turbo and fPELA turbo assays – U.S. and Outside U.S.: VITROS XT 7600 and 5600 Integrated System, as well as VITROS 4600 Chemistry Systems.